Compare CSPI & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSPI | ECOR |
|---|---|---|
| Founded | 1968 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.6M | 81.0M |
| IPO Year | 1994 | 2018 |
| Metric | CSPI | ECOR |
|---|---|---|
| Price | $8.49 | $7.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 27.6K | ★ 142.6K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.15% | N/A |
| EPS Growth | ★ 75.00 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $58,730,000.00 | $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $219.00 | ★ N/A |
| Revenue Growth | 6.36 | ★ 27.20 |
| 52 Week Low | $7.55 | $4.16 |
| 52 Week High | $15.00 | $10.50 |
| Indicator | CSPI | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 40.26 | 43.32 |
| Support Level | $7.98 | $4.75 |
| Resistance Level | $9.31 | $8.26 |
| Average True Range (ATR) | 0.69 | 0.93 |
| MACD | -0.04 | -0.33 |
| Stochastic Oscillator | 19.14 | 18.86 |
CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.